Related Experiment Videos
Thiol reducing compounds prevent human amylin-evoked cytotoxicity
Barbara Konarkowska1, Jacqueline F Aitken, Joerg Kistler
1The School of Biological Sciences, University of Auckland, New Zealand.
The FEBS Journal
|September 24, 2005
Summary
Human amylin causes cell damage in type-2 diabetes. Thiol antioxidants like NAC protect cells by targeting specific pathways, not just oxidative stress, offering a potential therapeutic strategy for halting disease progression.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Human amylin (hA) forms pancreatic islet amyloid, a hallmark of type-2 diabetes mellitus (T2Dm).
- hA toxicity contributes to the progressive loss of beta-cell function in T2Dm.
- Understanding hA's cytotoxic mechanisms is crucial for developing T2Dm therapies.
Purpose of the Study:
- To investigate the role of oxidative stress in hA-mediated cytotoxicity.
- To evaluate the protective effects of different antioxidant classes against hA toxicity.
Main Methods:
- Treatment of RINm5F cells with human amylin (hA).
- Assessment of intracellular reactive oxygen species (ROS) and glutathione (GSH) levels.
- Evaluation of protection offered by free radical scavengers (catalase, n-propyl gallate) and thiol antioxidants (N-acetyl-L-cysteine (NAC), GSH, dithiothreitol).
Main Results:
- hA treatment induced intracellular ROS accumulation.
- Thiol antioxidants (NAC, GSH, dithiothreitol) provided significant protection against hA-mediated cytotoxicity and apoptosis.
- Free radical scavengers offered limited protection.
- hA cytotoxicity and NAC protection were independent of intracellular GSH levels.
Conclusions:
- hA-mediated cytotoxicity involves both oxidative stress and redox-sensitive signaling pathways.
- Thiol antioxidants are effective in protecting cells from hA toxicity, suggesting a therapeutic potential for T2Dm.
- The mechanism of protection by thiol antioxidants involves more than just ROS scavenging.